Columbia Funds Series Trust I - Annual N-SAR report for the period
ending 11/30/10

Columbia Tax-Exempt Fund
(the "Fund")



Item 77B - Report of Independent Registered Public Accounting Firm


To the Trustees and Shareholders of Columbia Funds Series Trust I

In planning and performing our audit of the financial statements of the
Columbia Tax-Exempt Fund (a series of Columbia Funds Series Trust I and
hereafter referred to as the "Fund") as of and for the year ended
November 30, 2010, in accordance with the standards of the Public Company
Accounting Oversight Board (United States), we considered the Fund's internal
control over financial reporting, including controls over safeguarding
securities, as a basis for designing our auditing procedures for the
purpose of expressing our opinion on the financial statements and to comply
with the requirements of Form N-SAR, but not for the purpose of expressing
an opinion on the effectiveness of the Fund's internal control over financial
reporting.  Accordingly, we do not express an opinion on the effectiveness
of the Fund's internal control over financial reporting.

The management of the Fund is responsible for establishing and maintaining
effective internal control over financial reporting.  In fulfilling this
responsibility, estimates and judgments by management are required to assess
the expected benefits and related costs of controls.  A fund's internal
control over financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with
generally accepted accounting principles.  A fund's internal control over
financial reporting includes those policies and procedures that (1) pertain
to the maintenance of records that, in reasonable detail, accurately and
fairly reflect the transactions and dispositions of the assets of the fund;
(2) provide reasonable assurance that transactions are recorded as necessary
to permit preparation of financial statements in accordance with generally
accepted accounting principles, and that receipts and expenditures of the
fund are being made only in accordance with authorizations of management and
trustees of the fund; and (3)  provide reasonable assurance regarding
prevention or timely detection of unauthorized acquisition, use or
disposition of a fund's assets that could have a material effect on the
financial statements.

Because of its inherent limitations, internal control over financial
reporting may not prevent or detect misstatements.  Also, projections of
any evaluation of effectiveness to future periods are subject to the
risk that controls may become inadequate because of changes in conditions,
or that the degree of compliance with the policies or procedures
may deteriorate.

A deficiency in internal control over financial reporting exists when
the design or operation of a control does not allow management or employees,
in the normal course of performing their assigned functions, to prevent or
detect misstatements on a timely basis.  A material weakness is a deficiency,
or a combination of deficiencies, in internal control over financial
reporting, such that there is a reasonable possibility that a material
misstatement of the Fund's annual or interim financial statements will
not be prevented or detected on a timely basis.

Our consideration of the Fund's internal control over financial reporting
was for the limited purpose described in the first paragraph and would not
necessarily disclose all deficiencies in internal control over financial
reporting that might be material weaknesses under standards established by
the Public Company Accounting Oversight Board (United States).  However,
we noted no deficiencies in the Fund's internal control over financial
reporting and its operation, including controls over safeguarding
securities that we consider to be material weaknesses as defined
above as of November 30, 2010.


This report is intended solely for the information and use of management
and the Board of Trustees of the Fund and the Securities and Exchange
Commission and is not intended to be and should not be used by
anyone other than these specified parties.


/s/PricewaterhouseCoopers LLP

Boston, Massachusetts
January 21, 2011



Item 77D/77Q1(b) - Policies with Respect to Securities Investments:

On October 26, 2010, a Form Type 497, Accession No.  0001193125-10-236505,
which included a supplement to the registration statement of Columbia Funds
Series Trust I, was filed with the SEC.  This is  hereby incorporated by
reference as part of the response to the Items 77D and 77Q1(b) of
Form N-SAR. The supplement disclosed, among other things, a change that was
made to the section of the Fund's prospectuses entitled "Principal
Investment Strategies."


Item 77E - Legal Proceedings:

Information Regarding Pending and Settled
Legal Proceedings

In June 2004, an action captioned John E. Gallus et al. v.
American Express Financial Corp. and American Express
Financial Advisors Inc. was filed in the United States District
Court for the District of Arizona. The plaintiffs allege that they
are investors in several American Express Company (now
known as legacy RiverSource) mutual funds and they purport
to bring the action derivatively on behalf of those funds under
the Investment Company Act of 1940. The plaintiffs allege that
fees allegedly paid to the defendants by the funds for
investment advisory and administrative services are excessive.
The plaintiffs seek remedies including restitution and
rescission of investment advisory and distribution
agreements. The plaintiffs voluntarily agreed to transfer this
case to the United States District Court for the District of
Minnesota (the District Court). In response to defendants'
motion to dismiss the complaint, the District Court dismissed
one of plaintiffs' four claims and granted plaintiffs limited
discovery. Defendants moved for summary judgment in
April 2007. Summary judgment was granted in the defendants'
favor on July 9, 2007. The plaintiffs filed a notice of appeal with
the Eighth Circuit Court of Appeals (the Eighth Circuit) on
August 8, 2007. On April 8, 2009, the Eighth Circuit reversed
summary judgment and remanded to the District Court for
further proceedings. On August 6, 2009, defendants filed a
writ of certiorari with the U.S. Supreme Court (the Supreme
Court), asking the Supreme Court to stay the District Court
proceedings while the Supreme Court considers and rules in a
case captioned Jones v. Harris Associates, which involves issues
of law similar to those presented in the Gallus case. On
March 30, 2010, the Supreme Court issued its ruling in
Jones v. Harris Associates, and on April 5, 2010, the Supreme
Court vacated the Eighth Circuit's decision in the Gallus case
and remanded the case to the Eighth Circuit for further
consideration in light of the Supreme Court's decision in
Jones v. Harris Associates. On June 4, 2010, the Eighth Circuit
remanded the Gallus case to the District Court for further
consideration in light of the Supreme Court's decision in
Jones v. Harris Associates. On December 9, 2010, the District
Court reinstated its July 9,2007 summary judgment order in
favor of the defendants.

In December 2005, without admitting or denying the
allegations, American Express Financial Corporation (AEFC,
which is now known as Ameriprise Financial, Inc. (Ameriprise
Financial)), entered into settlement agreements with the
Securities and Exchange Commission (SEC) and Minnesota
Department of Commerce (MDOC) related to market timing
activities. As a result, AEFC was censured and ordered to
cease and desist from committing or causing any violations of
certain provisions of the Investment Advisers Act of 1940, the
Investment Company Act of 1940, and various Minnesota laws.
AEFC agreed to pay disgorgement of $10 million and civil
money penalties of $7 million. AEFC also agreed to retain an
independent distribution consultant to assist in developing a
plan for distribution of all disgorgement and civil penalties
ordered by the SEC in accordance with various undertakings
detailed at http://www.sec.gov/litigation/admin/ia-2451.pdf.
Ameriprise Financial and its affiliates have cooperated with
the SEC and the MDOC in these legal proceedings, and have
made regular reports to the funds' Boards of Directors/Trustees.
Ameriprise Financial and certain of its affiliates have
historically been involved in a number of legal, arbitration and
regulatory proceedings, including routine litigation, class
actions, and governmental actions, concerning matters arising
in connection with the conduct of their business activities.
Ameriprise Financial believes that the Funds are not currently
the subject of, and that neither Ameriprise Financial nor any
of its affiliates are the subject of, any pending legal,
arbitration or regulatory proceedings that are likely to have a
material adverse effect on the Funds or the ability of
Ameriprise Financial or its affiliates to perform under their
contracts with the Funds. Ameriprise Financial is required to
make 10-Q, 10-K and, as necessary, 8-K filings with the
Securities and Exchange Commission on legal and regulatory
matters that relate to Ameriprise Financial and its affiliates.
Copies of these filings may be obtained by accessing the SEC
website at www.sec.gov.

There can be no assurance that these matters, or the adverse
publicity associated with them, will not result in increased
fund redemptions, reduced sale of fund shares or other
adverse consequences to the Funds. Further, although we
believe proceedings are not likely to have a material adverse
effect on the Funds or the ability of Ameriprise Financial or its
affiliates to perform under their contracts with the Funds,
these proceedings are subject to uncertainties and, as such,
we are unable to estimate the possible loss or range of loss
that may result. An adverse outcome in one or more of these
proceedings could result in adverse judgments, settlements,
fines, penalties or other relief that could have a material
adverse effect on the consolidated financial condition or
results of operations of Ameriprise Financial.



Item 77I/77Q1(d) - Terms of new or amended securities:

An Amended and Restated Multi-Class Plan, pursuant to Rule 18f-3(d), for
the Fund dated September 7, 2010 is incorporated by reference to
Post-Effective Amendment No. 111 to the Registration Statement of the
Registrant on Form Type 485(b) filed on September 27, 2010,
Accession No. 0001193125-10-217500.